Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed)
ID: PAR-20-098 • Type: Posted
Overview
Category of Funding
Health
Funding Instruments
Grant
Grant Program (CFDA)
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 2/6/20 the National Institutes of Health posted grant opportunity PAR-20-098 for Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed).
The grant will be issued under grant program 93.350 National Center for Advancing Translational Sciences.
Timing
Posted Date
Feb. 6, 2020, 12:00 a.m. EST
Closing Date
Jan. 5, 2022, 12:00 a.m. EST Past Due
Last Updated
Feb. 6, 2020, 9:58 a.m. EST
Version
1
Archive Date
Feb. 10, 2022
Eligibility
Eligible Applicants
Small businesses
Additional Info
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Contacts
Contact
National Institutes of Health
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 496-3405
Additional Information Site